Hims & Hers Health (HIMS) Total Current Liabilities (2019 - 2026)

Hims & Hers Health (HIMS) reported Total Current Liabilities of $618.8 million for Q1 2026, up 120.71% on a YoY basis from $280.4 million in Q1 2025, and up 53.0% sequentially from $404.4 million in Q4 2025.

Hims & Hers Health (HIMS) Total Current Liabilities (2019 - 2026) Analysis & Trends

Hims & Hers Health (HIMS) has 8 years of Total Current Liabilities data on file, last reported at $618.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Current Liabilities rose 120.71% year-over-year to $618.8 million; the trailing twelve-month figure through Mar 2026 stood at $618.8 million (up 120.71% YoY), and the FY2025 full-year result was $404.4 million, up 82.7% from the prior year.
  • Total Current Liabilities rose to $618.8 million in Q1 2026, from $404.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $618.8 million in Q1 2026 to a low of $47.9 million in Q4 2022.
  • A 5-year average of $183.3 million and a median of $93.3 million in 2024 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities sank 39.48% in 2022 and jumped 200.42% in 2025, its largest moves.
  • Tracing HIMS's Total Current Liabilities over 5 years: stood at $47.9 million in 2022, then jumped by 84.54% to $88.5 million in 2023, then jumped by 150.22% to $221.4 million in 2024, then surged by 82.7% to $404.4 million in 2025, then surged by 53.0% to $618.8 million in 2026.
  • Business Quant data shows HIMS's Total Current Liabilities at $618.8 million in Q1 2026, $404.4 million in Q4 2025, and $450.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 599.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 19.22 Mn
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 1.66 Bn
10 Hims & Hers Health 6.44 Bn 5.69 Bn 396.79 Mn 618.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 618.78 Mn
Dec 31, 2025 404.43 Mn
Sep 30, 2025 450.79 Mn
Jun 30, 2025 272.23 Mn
Mar 31, 2025 280.36 Mn
Dec 31, 2024 221.37 Mn
Sep 30, 2024 152.65 Mn
Jun 30, 2024 108.67 Mn
Mar 31, 2024 93.32 Mn
Dec 31, 2023 88.47 Mn
Sep 30, 2023 82.55 Mn
Jun 30, 2023 66.55 Mn
Mar 31, 2023 56.28 Mn
Dec 31, 2022 47.94 Mn
Sep 30, 2022 66.82 Mn
Jun 30, 2022 55.62 Mn
Mar 31, 2022 48.50 Mn
Dec 31, 2021 79.22 Mn
Sep 30, 2021 52.50 Mn
Jun 30, 2021 27.34 Mn